Cy5.5 NHS Ester: Precision Near-Infrared Biomolecule Labeling for Advanced Optical Imaging

Principle Overview: Why Cy5.5 NHS Ester (Non-Sulfonated) Sets the Benchmark

Cy5.5 NHS ester (non-sulfonated) is a next-generation near-infrared fluorescent dye for biomolecule labeling engineered for the highest specificity and performance in molecular biology and translational research. Boasting an excitation maximum at 684 nm and emission at 710 nm, this dye operates in the near-infrared (NIR) spectrum—an ideal window for deep-tissue imaging and in vivo fluorescence imaging where background autofluorescence is minimized and penetration depth is maximized.

The core of Cy5.5 NHS ester's utility lies in its robust NHS ester chemistry that targets primary amines on peptides, proteins, and oligonucleotides. This selective covalent labeling forms stable amide bonds, guaranteeing durable fluorescence signals in even the most challenging biological environments. As an amino group labeling reagent, it is especially valued for:

• High-efficiency conjugation to biomolecules in aqueous buffers (with organic co-solvent mediation)
• Compatibility with a broad range of proteins and nucleic acids
• Exceptional stability (24 months as a solid at -20°C, light-protected)

Cy5.5 NHS ester’s proven performance as a tumor imaging agent and as a probe in optical imaging of tumors underscores its impact in both preclinical and translational research workflows (see integration with nanotheranostic platforms).

Step-by-Step Protocol: Optimized Labeling Workflow for Reproducibility

1. Reagent Preparation

• Storage: Maintain Cy5.5 NHS ester at -20°C, protected from light. Only open the vial in subdued lighting.
• Dissolution: Immediately before use, dissolve the dye in dry DMSO or DMF (recommended: ≥35.82 mg/mL in DMSO). Avoid aqueous solvents at this stage due to hydrolysis risk.

2. Biomolecule Buffer Exchange

• Transfer the target protein, peptide, or oligonucleotide into a labeling-compatible buffer (e.g., 0.1 M sodium bicarbonate, pH 8.3). Avoid primary amine-containing buffers (e.g., Tris).
• Desalt or concentrate as necessary to remove interfering substances.

3. Conjugation Reaction

• Add the Cy5.5 NHS ester solution to the biomolecule at a typical molar ratio of 3–10:1 (dye:protein).
• Incubate for 30–60 min at room temperature, shielded from light.
• Quench unreacted NHS ester with 10 mM glycine if desired.

4. Purification

• Remove free dye by gel filtration (e.g., Sephadex G-25), spin column, or dialysis into a storage buffer.

5. Quantitative Characterization

• Measure absorbance at 684 nm and protein concentration to calculate degree of labeling (DOL). Ideal DOL: 1–3 dyes per biomolecule for most imaging applications.

For detailed tips on protocol adjustments and assay compatibility, see this optimization guide which complements the workflow above by addressing cell-based assay nuances.

Applied Use-Cases: From Tumor Imaging to Piezo-Nanoplatforms

Deep-Tissue and In Vivo Fluorescence Imaging

Cy5.5 NHS ester (non-sulfonated) shines in in vivo fluorescence imaging and optical imaging of tumors due to its NIR spectral window. Quantitative studies demonstrate that Cy5.5-labeled antibodies and nanoparticles enable clear tumor delineation in live animal models, with tumor-to-background ratios exceeding 5:1 at 24 hours post-injection (reference).

Molecular Imaging and Neuroscience Integration

Advanced nanoplatforms, such as those described in the recent study on ultrasound-triggered piezo-nanoplatforms for epilepsy treatment, leverage Cy5.5 NHS ester to fluorescently label piezoelectric nanoparticles or surface-bound ligands. This allows researchers to non-invasively track nanoplatform distribution, confirm tissue targeting, and correlate localization with therapeutic efficacy in real time. The synergy between the dye’s deep-tissue penetration and the wireless neuromodulation capacity of these platforms is transforming neuroscience imaging and intervention.

For a broader strategic context and competitive analysis, this thought-leadership article extends the discussion by comparing Cy5.5 NHS ester to other near-infrared dyes in neuromodulation and translational imaging.

Multiplexed and Longitudinal Imaging

The defined Cy5.5 excitation emission profile (684/710 nm) fits seamlessly into multiplexed imaging panels, minimizing spectral overlap with Cy3, Cy5, or IRDye series. This facilitates simultaneous multi-target tracking in vivo, crucial for studies in tumor microenvironment, immune cell migration, and targeted drug delivery.

Troubleshooting & Optimization: Unlocking Reliable Performance

Common Pitfalls and Solutions

• Low Labeling Efficiency: Confirm that the biomolecule is in a primary amine-compatible buffer. Re-exchange into 0.1 M sodium bicarbonate, pH 8.3, and avoid amine contaminants. Ensure fresh dye is used and dissolved immediately before the reaction.
• Precipitation During Labeling: Gradually add the dye solution to the biomolecule with gentle mixing. If precipitation persists, lower the dye-to-protein ratio or increase organic co-solvent content up to 10% (v/v).
• High Background Fluorescence: Ensure thorough removal of free dye after conjugation via size-exclusion or repeated buffer exchange. Validate with absorbance scans for residual unconjugated dye.
• Hydrolysis of NHS Ester: Perform all steps swiftly and use anhydrous solvents. Store the solid dye at -20°C, protected from light, and never freeze-thaw solutions.

Advanced Tips

• For highly sensitive applications (e.g., single-cell or subcellular imaging), optimize the degree of labeling to minimize signal quenching.
• For nanoparticle surface labeling, pre-activate surfaces with primary amines and confirm surface coverage by spectrophotometric or fluorometric analysis.
• When conjugating to oligonucleotides, ensure removal of ammonium acetate or other nucleophile-containing buffers prior to labeling.

For further troubleshooting and workflow refinements, the resource "Cy5.5 NHS Ester: Advanced Near-Infrared Fluorescent Dye for Molecular Imaging" complements these tips with real-world troubleshooting case studies.

Comparative Advantages: Why Choose APExBIO’s Cy5.5 NHS Ester?

Among available fluorescent dyes for protein conjugation, APExBIO’s Cy5.5 NHS ester (non-sulfonated) stands out for:

• Superior Solubility: ≥35.82 mg/mL in DMSO ensures stock solutions for high-throughput labeling.
• Exceptional Photostability: Stable for 24 months as a solid, and robust during extended imaging sessions.
• Optimized for In Vivo Use: Reduced background and increased tissue penetration in the NIR window (cy5.5, cy5 nhs ester advantages).
• Vendor Reliability: APExBIO is recognized for consistent product quality and technical support, critical for reproducibility in regulated and high-stakes studies.

In head-to-head comparisons, Cy5.5 NHS ester consistently delivers higher signal-to-noise ratios and superior tumor imaging contrast compared to legacy dyes. Its performance is especially notable in tumor imaging agent applications, producing clear delineation in animal models even at low nanomole-level doses.

Future Outlook: Expanding the Frontier of Molecular Imaging

Looking forward, Cy5.5 NHS ester (non-sulfonated) is poised to accelerate innovation as new imaging modalities and nanotechnology platforms emerge. Its compatibility with ultrasound-responsive piezo-nanoplatforms—as demonstrated in recent epilepsy neuromodulation research (Li et al., 2025)—signals a future where fluorescence labeling, real-time diagnostics, and precision therapy converge.

Expanding applications in multiplexed in vivo fluorescence imaging, longitudinal tracking of therapeutic cells, and integration with theranostic nanoparticles will further cement Cy5.5 NHS ester’s role as a foundational tool in molecular biology research and preclinical development. As imaging requirements become more sophisticated, the demand for dyes with defined excitation emission cy5.5 profiles and robust conjugation chemistry will only grow.

For comprehensive background and evolving strategies, consult "Translational Frontiers: Mechanistic and Strategic Imperatives" for an in-depth analysis of Cy5.5 NHS ester in next-generation bio-conjugation and imaging workflows.

Conclusion

Cy5.5 NHS ester (non-sulfonated) from APExBIO is a cornerstone fluorescent labeling reagent for researchers pursuing the limits of sensitivity, specificity, and translational relevance in molecular imaging. Its optimized chemistry, NIR photophysics, and proven track record in preclinical models make it the preferred choice for deep-tissue imaging, tumor visualization, and advanced nanomedicine applications. By following best-practice protocols, leveraging interlinked resources, and proactively troubleshooting, scientists can unlock the full potential of Cy5.5 NHS ester in their most demanding workflows.